Valuation (86%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 4.02 | N/A |
| PEG Ratio (TTM) | -0.12 | N/A |
| P/S Ratio (TTM) | 0.27 | N/A |
| P/B Ratio (TTM) | 0.29 | N/A |
| P/FCF Ratio (TTM) | 7.19 | N/A |
| Price to 5YR AVG Earnings Ratio | 0.30 | N/A |
| Price to 5YR AVG FCF Ratio | 0.55 | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.88% | N/A |
| ROE (TTM) | 7.07% | N/A |
| Net Profit Margin (TTM) | 6.28% | N/A |
| ROIC 5YR AVG | 16.20% | N/A |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 28.50% | -21.64% | -4.29% |
| Revenue | -13.96% | -1.65% | -0.99% |
| Net Income | 28.97% | -24.58% | -6.25% |
| Cash Flow | 46.37% | -3.25% | -5.34% |
Health (72%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.59 | N/A |
| Quick Ratio (TTM) | 2.59 | N/A |
| D/E Ratio (TTM) | 0.05 | N/A |
| Interest Coverage (TTM) | 39.14 | N/A |
| Piotroski F-Score | 4 | N/A |
| Altman Z-Score | 1.93 | N/A |
| LTL to 5YR AVG FCF | 0.45 | N/A |
| Shares Outstanding Growth 5YR AVG | -2.62% | N/A |